ONCODERMA
ActiveSummary
The computed 12-month bankruptcy probability of ONCODERMA is 2.4% (moderate). The 2024 annual accounts show negative equity (-€32,664) and a net result of -€9,156. Equity is shrinking by about 33% per year across the filed financial years. Its solvency ranks better than 5% of 2,031 sector peers (NACE 77, financial year 2024). The company has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals.
Financials · financial year 2024, micro format
2020 to 2024, 5 financial years 2018 to 2024, 7 financial years
The operating result stays negative: a loss of €8,244 in 2024 against €6,523 in 2023; the loss grows.
What the company sold each financial year and what was left of it. A loss stands below the zero line.
What the company owns (total assets), how much of it is its own (equity) and how much it owes.
Short-term assets minus short-term debts. Above zero the company can pay its bills in the short term.
How much of each euro of turnover is left from operations (EBIT margin) and what the assets earn (return on assets).
The share of the company financed with its own means. The higher it is, the better it absorbs a shock.
Short-term assets per euro of short-term debt. Above 1 the short-term debts are covered.
Use the arrow keys on the chart for the figures per year.
Sector: the middle half of NACE 77, Rental and leasing activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Peer companies
Historical observationOf the 6,906 companies that looked in July 2024 the way this one looks now, 5.8% went bankrupt within 24 months and 85% are still going.
- Micro
- 10 to 20 years old
- negative equity
- a loss of 10% of the balance sheet or more
A further 0.6% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of 2.4% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,472 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,906 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | - | - | €259 | €592 | €592 | €592 | €592 | = |
| Other operating charges640/8 | - | - | - | €373 | - | - | €2,578 | - |
| Gross operating margin9900 | €16,582 | -€2,308 | €1,599 | -€10,254 | -€2,740 | -€5,931 | -€5,074 | ▲ 14.4% |
| Operating profit (loss)9901 | -€42,504 | -€2,710 | €554 | -€11,219 | -€3,332 | -€6,523 | -€8,244 | ▼ 26.4% |
| Recurring financial income75 | €10 | - | - | - | - | - | - | - |
| Financial charges65/66B | - | - | - | €200 | €781 | €182 | €911 | ▲ 402% |
| Recurring financial charges65 | €948 | €217 | €444 | €200 | €781 | €182 | €911 | ▲ 402% |
| Profit (loss) for the period before taxes9903 | -€209,772 | €403,085 | €110 | -€11,420 | -€4,114 | -€6,705 | -€9,156 | ▼ 36.6% |
| Income taxes67/77 | - | €421 | - | - | - | - | - | - |
| Profit (loss) for the period9904 | -€209,772 | €402,664 | €110 | -€11,420 | -€4,114 | -€6,705 | -€9,156 | ▼ 36.6% |
| Profit (loss) for the period to be appropriated9905 | -€209,772 | €402,664 | €110 | -€11,420 | -€4,114 | -€6,705 | -€9,156 | ▼ 36.6% |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €342 | €259 | €24,925 | €5,312 | €4,885 | €1,492 | €602 | ▼ 59.6% |
| Fixed assets21/28 | - | - | €2,701 | €2,109 | €1,517 | €925 | €333 | ▼ 64.0% |
| Intangible fixed assets21 | - | - | €2,701 | €2,109 | €1,517 | €925 | €333 | ▼ 64.0% |
| Current assets29/58 | €342 | €259 | €22,224 | €3,203 | €3,367 | €567 | €269 | ▼ 52.5% |
| Stocks and contracts in progress3 | - | - | €11,480 | €2,774 | €2,774 | - | - | - |
| Stocks30/36 | - | - | - | €2,774 | €2,774 | - | - | - |
| Amounts receivable within one year40/41 | €285 | €203 | €9,441 | €400 | €586 | €536 | €260 | ▼ 51.5% |
| Other amounts receivable41 | - | - | - | €400 | €586 | €536 | €260 | ▼ 51.5% |
| Cash at bank and in hand54/58 | €57 | €56 | €1,303 | €29 | €7 | €31 | €9 | ▼ 69.8% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €342 | €259 | €24,925 | €5,312 | €4,885 | €1,492 | €602 | ▼ 59.6% |
| Equity10/15 | -€404,044 | -€1,380 | -€1,270 | -€12,690 | -€16,803 | -€23,508 | -€32,664 | ▼ 38.9% |
| Contributions10/11 | €80,000 | €80,000 | - | €4,536 | €4,536 | €4,536 | €4,536 | = |
| Profit (loss) carried forward14 | -€484,044 | -€81,380 | -€5,806 | -€17,225 | -€21,339 | -€28,044 | -€37,200 | ▼ 32.6% |
| Amounts payable17/49 | €404,386 | €1,639 | €26,195 | €18,002 | €21,688 | €25,000 | €33,267 | ▲ 33.1% |
| Amounts payable after more than one year17 | €384,483 | - | €7,555 | €16,283 | €16,443 | €16,337 | €19,437 | ▲ 19.0% |
| Other amounts payable178/9 | - | - | - | €16,283 | €16,443 | €16,337 | €19,437 | ▲ 19.0% |
| Amounts payable within one year42/48 | €19,903 | €1,639 | €18,641 | €1,719 | €5,245 | €8,664 | €13,830 | ▲ 59.6% |
| Trade debts44 | - | €1,639 | €18,641 | €1,719 | €5,245 | €8,664 | €12,237 | ▲ 41.2% |
| Suppliers440/4 | - | - | - | €1,719 | €5,245 | €8,664 | €12,237 | ▲ 41.2% |
| Other amounts payable47/48 | - | - | - | - | - | - | €1,594 | - |
| Line | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | -€209,772 | €402,664 | €110 | -€11,420 | -€4,114 | -€6,705 | -€9,156 | ▼ 36.6% |
| + Depreciation and write-downs630 | - | - | €259 | €592 | €592 | €592 | €592 | = |
| Operating cash flow (approximation) | -€209,772 | €402,664 | €369 | -€10,828 | -€3,522 | -€6,113 | -€8,564 | ▼ 40.1% |
| Investment in fixed assets (approximation) | - | - | - | €0 | €0 | €0 | €0 | - |
| Change in cash | - | -€1 | €1,247 | -€1,274 | -€22 | €23 | -€21 | ▼ 192% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Similar companies · same sector and region
Public contracts: not fully processed yet. The notices from October 2017 to September 2026 are still being read.